Related Experiment Videos
Clearance of human native, proteinase-complexed, and proteolytically inactivated C1-inhibitor in rats
B J de Smet1, J P de Boer, J Agterberg
1Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam.
Insights
The study reveals that C1-inhibitor (C1-INH) complexes are cleared rapidly from plasma, unlike native C1-INH. This rapid clearance explains low observed C1-INH complex levels in patients with activated complement or contact systems.
Area of Science:
- Biochemistry
- Immunology
- Hematology
Background:
- C1-inhibitor (C1-INH) is crucial for regulating complement and coagulation pathways.
- C1-INH exists in native, proteinase-complexed, and inactivated forms, each with distinct properties.
- Understanding C1-INH kinetics is vital for interpreting its role in various physiological and pathological states.
Purpose of the Study:
- To investigate the plasma elimination kinetics of the three distinct human C1-inhibitor conformations.
- To compare the clearance rates of native, proteinase-complexed, and inactivated C1-inhibitor.
- To elucidate the implications of C1-INH clearance for its observed concentrations in patients.
Main Methods:
- Studied plasma elimination kinetics of human C1-inhibitor forms in a rat model.
- Measured plasma half-lives (t1/2) for native, C1s-C1-INH, kallikrein-C1-INH, betaXIIa-C1-INH, and inactivated C1-INH.
- Analyzed the impact of different proteinases on the clearance of C1-INH complexes.
Main Results:
- Complexed C1-inhibitor exhibited the most rapid clearance, with plasma t1/2 ranging from 20 to 47 minutes depending on the proteinase.
- Native C1-inhibitor showed the slowest clearance, with a plasma t1/2 of 4.5 hours.
- Inactivated C1-inhibitor had an intermediate plasma t1/2 of 1.6 hours.
Conclusions:
- The rapid clearance of C1-inhibitor complexes significantly influences their circulating levels.
- Observed low concentrations of C1-INH complexes in patients can be attributed to their rapid elimination.
- These findings provide a kinetic explanation for C1-INH complex levels during contact and complement system activation.
Abstract:
C1-inhibitor is the only known inhibitor of the classical pathway of complement and the major inhibitor of the contact pathway of coagulation. Like other serine proteinase inhibitors, C1-inhibitor can exist in three conformations, ie, the native, the proteinase-complexed, and the proteolytically inactivated form. Here we studied the plasma elimination kinetics of these three forms of human C1-inhibitor in rats. The clearance of the complexed form of C1-inhibitor appeared to be the most rapid and depended in part on the proteinase involved (observed plasma t1/2 was 20 minutes for C1s-C1-inhibitor, 32 minutes for kallikrein-C1-inhibitor, and 47 minutes for beta XIIa-C1-inhibitor), whereas that of native C1-inhibitor was the slowest (observed plasma t1/2 4.5 hours). Inactivated C1-inhibitor was cleared with an apparent plasma t1/2 of 1.6 hours. Thus, the short plasma t1/2 of complexed relative to native C1-inhibitor explains why in patients only low concentrations of C1-inhibitor complexes may be observed despite activation of the contact and/or complement systems.